PF

PB Fintech Ltd

Q3 FY26Financial Technology (Fintech)

PB Fintech Ltd Q3 FY26 Results & Concall Highlights: Revenue, Margins & Order Book

Q3 FY26 earnings call: what management guided on revenue, margins and order book.

Price1,795
Market cap₹80.6K Cr
P/E107.7
Updated23 Aug 2026
Read4 min read

The short version

Term and health insurance currently make up around half the business, with term growing about 70%. Term and health insurance currently make up around half of the business, with health insurance growing about 70% YoY recently.

From PB Fintech Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Term and health insurance currently make up around half the business, with term growing about 70%.
  • Growth in health insurance largely driven by an increase in the number of customers; ticket size growth is smaller.
  • Long-term health insurance growth of around 30% is considered sufficient and sustainable; current high growth likely not consistent at present pace but could continue near this level.
  • Growth fueled by fresh customers rather than policy renewals or portability.
  • Sustained growth attributed to strong customer trust, better claims experience, and quality risk disclosure enabling appropriate pricing.
  • Renewals growth in health is starting to accelerate following the strong new business growth.
  • Market leadership in health and life insurance expected to continue driving above-industry growth (about 40% higher than market).
  • International expansion being considered cautiously, focusing on strategic fit, market size, and financial benchmarks before proceeding.

Profitability & Margins

See what PB Fintech Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Management discussed potential acquisitions as part of future capital allocation strategy, seeking board and shareholder approval for a QIP (Qualified Institutional Placement) to fund these activities.
  • Acquisitions would focus on strategically fitting large markets with stable players where Policybazaar's skills can add value, leveraging Indian expertise and local strengths.
  • Investments will be EPS/PE accretive and value-driven, focusing on transforming acquired companies to be more competitive.
  • Besides acquisitions, minor investments may be made in new initiatives like the Pension model once optimized.
  • Capital allocation will also consider diversification both within India and internationally.
  • The company aims to fund growth initiatives internally from current accruals and cash reserves (~₹5,000 Cr cash on the balance sheet).
  • No large-scale capex beyond acquisitions mentioned; infrastructure investments noted for PB Health hospitals under development.

Top-ranked in Financial Technology (Fintech)

Ranked on what management guided this quarter

5x potential
1Network People
Rev 1Mar 1
2AvenuesAI
Rev 1Mar 3
3
Rev 2Mar 3
4
Rev 2Mar 3
5
Rev 2Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what PB Fintech Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The provided transcript from the document does not mention any information regarding the current or expected order book or pending orders for the company. The discussion primarily revolves around business growth, commission structures, international expansion, product mix, profitability, and capital allocation strategies. There is no reference to order books, sales backlog, or pending orders in the excerpts from pages 5 to 21. Therefore, no details can be provided on current or expected order book/pending orders based on the available content.

PB Fintech Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹2.1K Cr, net profit ₹261 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Financial Technology (Fintech) this season

  • Seshaasai Technologies Ltd (Q3 FY26)

    Q3 FY26 showed 10.1% Y-o-Y revenue growth and 19.3% Y-o-Y PAT growth with a PAT margin of 17.15% . Key concall takeaways from Seshaasai Tech.'s Q3 FY26…

  • AvenuesAI Ltd (Q3 FY26)

    EBITDA showed a 25% year-over-year increase, with improved operating leverage as volumes scale. Key concall takeaways from AvenuesAI Ltd's Q3 FY26 earnings…

  • Pine Labs Ltd (Q3 FY26)

    Issuance business grew 42%, digital payments business grew 16%, contributing to overall 24% revenue growth year-over-year. Key concall takeaways from Pine Labs…

  • One 97 Communications Ltd (Q3 FY26)

    Device growth in merchant business remains robust with approximately 27 lakh new devices added annually, and potential penetration rising up to 20% (Page 20)…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were PB Fintech Ltd Q3 FY26 results?

Term and health insurance currently make up around half the business, with term growing about 70%. Term and health insurance currently make up around half of the business, with health insurance growing about 70% YoY recently.

What is PB Fintech Ltd share price analysis?

PB Fintech Ltd currently shows a neutral. The stock trades at a P/E of 107.7 with a market cap of ₹80,555 Cr. Investors should review the full earnings analysis for detailed insights.

Is PB Fintech Ltd planning capital expenditure?

Management discussed potential acquisitions as part of future capital allocation strategy, seeking board and shareholder approval for a QIP (Qualified Institutional Placement) to fund these activities.

Keep PB Fintech Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.